| Similar Articles |
|---|
 |
The Motley Fool
October 16, 2009
Robert Steyer |
Baxter Beats Again -- the Streak Is Alive! The drug, device, and medical services giant beats Wall Street earnings estimates by a penny, but flat sales signal caution.   |
Pharmaceutical Executive
August 1, 2014
Ben Comer |
Pharm Exec's 2014 Emerging Pharma Leaders This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise. |
The Motley Fool
January 23, 2009
Robert Steyer |
BAX to the Future After minding its own business, Baxter International starts thinking about acquisitions again. |
The Motley Fool
April 17, 2009
Robert Steyer |
The Steady BAX Beat Baxter International's diverse medical offerings continue to produce prosperity. |
HBS Working Knowledge
August 2, 2004
Wendy Guild Swearingen |
Health Care Research and Prospects This interview with Professor Gary P. Pisano discusses a groundbreaking project at Harvard Business School that is bringing together faculty, researchers, and students to probe issues in health care management. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
Baxter Bags Better Margins This is a great business -- but only at the right price. Investors, this story has to be bought cheap. At today's prices, is it cheap enough? |
